Loading stock data...

Indegene Limited

NSE: INDGN BSE: INDGN

NSE
539.40 -12.65 (-2.29%)

Prev Close

552.05

Open Price

555.85

Volume

445,662

Today Low / High

534 / 556.4

52 WK Low / High

499 / 735

Range

512 - 566

BSE
540.65 -11.75 (-2.13%)

Prev Close

552.4

Open Price

555.1

Volume

45,304

Today Low / High

534 / 555.15

52 WK Low / High

485.15 / 735

Range

514 - 568

The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 539.4 (target range: 512 - 566), reflecting a change of -12.65 (-2.29146%). On the BSE, it is listed at 540.65 (target range: 514 - 568), showing a change of -11.75 (-2.12708%). The stock price is currently in decline on both exchanges, signaling a downtrend. If you're considering investing in this stock, it's important to monitor the situation closely.

30 Oct 546.00 0.79%
29 Oct 550.85 -0.97%
28 Oct 541.95 1.06%
27 Oct 542.80 0.10%
24 Oct 542.00 -0.34%
23 Oct 554.70 -1.51%
21 Oct 559.65 -0.88%
20 Oct 542.95 2.55%
17 Oct 543.90 -0.23%
16 Oct 546.00 -1.13%
15 Oct 537.00 1.41%
14 Oct 549.90 -3.14%
13 Oct 554.10 -1.04%
10 Oct 551.10 1.01%
09 Oct 554.90 -0.25%
08 Oct 555.00 -0.84%
07 Oct 570.90 -3.35%
06 Oct 585.75 -2.36%
03 Oct 565.95 2.44%

Indegene Limited Graph

Indegene Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Indegene Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 539.40, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 540.65 546.06 491.45 - 600.66
551.46 441.17 - 661.76
556.87 389.81 - 723.93
Bearish Scenario 540.65 535.24 481.72 - 588.77
529.84 423.87 - 635.80
524.43 367.10 - 681.76

Overview of Indegene Limited

ISIN

INE065X01017

Industry

Medical - Healthcare Information Services

Vol.Avg

488,919

Market Cap

132,279,499,251

Last Dividend

2

Official Website

Visit Website

IPO Date

2024-05-13

DCF Diff

-19.55

DCF

565

Financial Ratios Every Investor Needs

Stock Dividend of INDGN

Date Label Adj Dividend Dividend Record Date Payment Date Declaration Date
2025-06-13 June 13, 25 2 2 2025-06-13 2025-07-26

Stock Rating Details for INDGN

Metric Value Recommendation
Overall Rating B- Sell
DCF Score 4 Buy
ROE Score 4 Buy
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 2 Sell
Price-to-Book (PB) Score 2 Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 2,839.30 Cr 2,067.20 Cr 772.10 Cr 0.2719 0.00 Cr 0.00 Cr 1,024.10 Cr 406.70 Cr 17.15 534.30 Cr 0.1432
2024-03-31 2,589.60 Cr 58.80 Cr 2,530.80 Cr 0.9773 0.00 Cr 0.00 Cr 874.80 Cr 336.70 Cr 14.09 584.10 Cr 0.1300
2023-03-31 2,306.13 Cr 1,725.16 Cr 580.97 Cr 0.2519 0.00 Cr 85.81 Cr 339.25 Cr 266.10 Cr 11.12 454.19 Cr 0.1154
2022-03-31 1,664.61 Cr 1,054.93 Cr 609.68 Cr 0.3663 0.00 Cr 54.46 Cr 255.56 Cr 164.76 Cr 7.51 265.91 Cr 0.0990
2021-03-31 966.27 Cr 565.23 Cr 966.27 Cr 1.0000 8.83 Cr 37.25 Cr 206.18 Cr 149.41 Cr 6.24 264.17 Cr 0.1546

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 374.60 Cr 3,325.90 Cr 710.30 Cr 2,615.6000 Cr 101.60 Cr -273.00 Cr 0.00 Cr 138.50 Cr 0.00 Cr 0.00 Cr 0.00 Cr 564.5000 Cr
2024-03-31 188.60 Cr 2,545.60 Cr 1,116.50 Cr 1,429.1000 Cr 489.60 Cr 301.00 Cr 0.00 Cr 114.40 Cr 35.20 Cr 0.00 Cr 0.00 Cr 610.9000 Cr
2023-03-31 73.59 Cr 2,203.87 Cr 1,140.14 Cr 1,063.7220 Cr 502.58 Cr 429.00 Cr 0.00 Cr 151.78 Cr 109.31 Cr 0.00 Cr 0.00 Cr 489.1460 Cr
2022-03-31 506.28 Cr 1,353.47 Cr 589.57 Cr 763.9000 Cr 65.75 Cr -440.53 Cr 0.00 Cr 79.88 Cr 187.19 Cr 0.00 Cr 0.00 Cr 440.4390 Cr
2021-03-31 133.36 Cr 596.04 Cr 262.96 Cr 324.5130 Cr 51.39 Cr -81.97 Cr 0.00 Cr 46.42 Cr 0.00 Cr 0.00 Cr 0.00 Cr 199.4290 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 441.9000 Cr -682.7000 Cr 287.5000 Cr 411.9000 Cr 52.4000 Cr 241.0000 Cr -30.0000 Cr 406.7000 Cr -403.1000 Cr 0.0000 Cr 0.0000 Cr
2024-03-31 507.7000 Cr -327.2000 Cr -66.2000 Cr 497.0000 Cr 115.0000 Cr 188.6000 Cr -10.7000 Cr 336.7000 Cr -34.6000 Cr 0.0000 Cr 0.0000 Cr
2023-03-31 130.2180 Cr -893.3480 Cr 333.0890 Cr 111.3840 Cr -432.6940 Cr 73.5850 Cr -18.8340 Cr 266.1000 Cr 376.0980 Cr 0.0000 Cr 0.0000 Cr
2022-03-31 297.0420 Cr -160.2070 Cr 233.4770 Cr 272.3330 Cr 372.9170 Cr 506.2790 Cr -24.7090 Cr 164.7620 Cr -23.2250 Cr 0.0000 Cr 0.0000 Cr
2021-03-31 172.0330 Cr -24.2490 Cr -131.5060 Cr 151.4170 Cr -40.4990 Cr 133.3620 Cr -20.6160 Cr 149.4050 Cr -126.4410 Cr 0.0000 Cr 0.0000 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-06-30 760.80 Cr 0.00 Cr 760.80 Cr 1.0000 133.70 Cr 116.40 Cr 4.86 177.40 Cr 0.1530
2025-03-31 755.60 Cr 0.00 Cr 755.60 Cr 1.0000 126.80 Cr 117.60 Cr 4.91 146.85 Cr 0.1556
2024-12-31 720.40 Cr 0.00 Cr 720.40 Cr 1.0000 111.80 Cr 109.70 Cr 4.59 169.50 Cr 0.1523
2024-09-30 686.80 Cr 580.10 Cr 106.70 Cr 0.1554 106.70 Cr 91.70 Cr 3.84 147.50 Cr 0.1335
2024-06-30 676.50 Cr 567.70 Cr 108.80 Cr 0.1608 108.80 Cr 87.70 Cr 3.79 151.40 Cr 0.1296

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-06-30 0.00 Cr 0.00 Cr 1,664.30 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -2,615.60 Cr
2025-03-31 374.60 Cr 1,289.70 Cr 1,664.30 Cr 751.40 Cr 0.00 Cr 2,530.00 Cr 138.50 Cr 3,325.90 Cr 710.30 Cr
2024-12-31 0.00 Cr 0.00 Cr 1,466.60 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -2,360.00 Cr
2024-09-30 311.90 Cr 1,154.70 Cr 1,466.60 Cr 718.80 Cr 0.00 Cr 2,289.50 Cr 110.70 Cr 3,024.10 Cr 664.10 Cr
2024-06-30 -987.50 Cr 1,975.00 Cr 987.50 Cr 0.00 Cr 0.00 Cr 987.50 Cr 0.00 Cr 0.00 Cr -1,429.10 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-06-30 116.40 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2025-03-31 117.60 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-12-31 109.70 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 91.70 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 87.70 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 188.60 Cr 188.60 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Medical - Healthcare Information Services

Company Name Symbol Price Market Cap Volume
Inventurus Knowledge Solutions Ltd. IKS ₹1,645.90 ₹274,989,706,997.00 ₹3,899,787.00
Sagility India Limited SAGILITY ₹52.54 ₹245,957,004,644.00 ₹200,081,807.00
Indegene Limited INDGN ₹539.40 ₹129,459,424,651.00 ₹445,662.00

Key Executives

Senior Vice President of Corporate Development
Mr. Shouvanik Chatterjee

Gender: male

Year Born:

Vice President of Legal & Group General Counsel
Mr. Karthik Kannappan Saravanan

Gender: male

Year Born:

Chairman & Chief Executive Officer
Mr. Manish Gupta

Gender: male

Year Born:

Senior Vice President of Global Growth Markets, Accounts & Medical Devices
Mr. Marut Setia

Gender: male

Year Born:

Senior Vice President of Global Operations
Mr. Pankaj Kakkar

Gender: male

Year Born:

Chief Financial Officer
Mr. Suhas Prabhu ACA, BCom

Gender: male

Year Born:

Chief Technology Officer
Mr. Tarun Mathur

Gender: male

Year Born:

Company Secretary & Compliance Officer
Ms. Srishti Ramesh Kaushik

Gender: female

Year Born:

Executive Vice President of Global Operations
Mr. Anand Kiran Prafula Chandra Nijegal

Gender: male

Year Born:

Executive Director & Executive Vice President
Dr. Sanjay Suresh Parikh Ph.D.

Gender: Not Specified

Year Born: 1963

FAQs about Indegene Limited

Who is the CEO of the company?

The CEO is Manish Gupta.

What is the current market price of the stock?

The current price is ₹551.15.

What is the 52-week price range?

The range is ₹499-735.

What is the market capitalization of the company?

The market capitalization is ₹13,227.95 crores.

What is the dividend yield?

The dividend yield is 0.36%.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 30.32.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Indegene Limited (ISIN: INE065X01017) is a leading Medical - Healthcare Information Services in India. With a market capitalization of ₹13,227.95 crores and an average daily volume of 488,919 shares, it operates in the Medical - Healthcare Information Services. The company last declared a dividend of ₹2.